July 9, 2021

Lynne Murray, PhD, MBA

Dr. Murray has served as Chief Scientific Officer for MiroBio since March 2022, having previously served as Senior Vice President of Research since joining in October 2020. Dr. Murray brings substantial experience in the discovery and development of pharmaceuticals from preclinical to Phase 2 in both large pharmaceutical and small biotech environments. Prior to joining MiroBio she served as Head of Regeneration at AstraZeneca’s early respiratory & immunology department. Over her tenure, she led multiple large and small molecule programs and gained significant business development experience in the partnering & strategy department at AZ. Before this, she was Director of Pharmacology at a U.S.-based biotech, Promedior and also held a research position at Janssen, Philadelphia after her postdoc at UCLA. Dr. Murray received her MBA from Judge Business School of the University of Cambridge and holds a Ph.D. in immunology and pathology from Imperial College London. She is an author of numerous publications and patents.

Your browser is out-of-date!

Update your browser to view this website correctly. Outdated Browser